| | 
Better Hearing is Better Living
Changing the Way You Hear
Hearing Systems
Experience More.
#1 Practice Management Software
Connect with possibilities
The leading innovator in sound processing
Work with us. Affiliate with us. Prosper with us.
Helping the World Hear Better
America's Audiology Network
Hear Now. And Always
Leader in the Hearing Assessment Market
Innovation beyond technology
The Science of Sound
Assistive Listening Devices and System
Audiological Equipment
It's time for something different.
Well known supplier of audiology and hearing aid supplies, accessories and equipment.
High-end industry-specific software and management services
Leading Diagnostic Solutions
The easy choice
HANSATON, the modern hearing systems manufacturer.
People First
Hearing Systems
Hearing Aid Batteries
|
|
Home | What's New | News | News Details
|
 
|
| |
Interview with Pat Henry, Director, Government Services, Wireless, and Pediatrics, Phonak
The N1-P2 Cortical Auditory Evoked Potential in Threshold Estimation
Interview with Denis Carpenter, Jeff Poirer, Randy Raymond, and Ann Rule, Rayovac
Interview with Pamela Paskowitz and Ellen Hansen
Multifrequency Tympanometry in Infants and Children
Interview with Michael Piskosz, M.S., Global Audiologist, ReSound
Current Candidates for a Bone Anchored Hearing Solution
Sonic Innovations Velocity: FAQs
Tinnitus Maskers, Therapy, and Insurance Coverage
Monthly Review - Keeping Things In Balance
Demographic Disparities Found Among Children with Frequent Ear Infections
Teen Hearing Loss On The Rise New Research Underscores Importance Of ASHA’s Buds Campaign
ADA 2010 Convention to Feature Good Company, Speaker Frank Bucaro
Sycle.net, the Industry's Number One Practice Management System, Announces New Team Member Julie Insinger
» More What's New |
|
10/24/2006
Chicago—For children with acute ear infections seen in an emergency department, giving parents the option of delaying use of antibiotics resulted in significantly lower use of antibiotics compared to parents who received a standard prescription, with little difference in the outcomes for the children, according to a study in the September 13 issue of JAMA.
Acute otitis media (AOM; ear infection) is the most common reason for which an antibiotic is prescribed to children. Treatment of AOM accounts for an estimated 15 million antibiotic prescriptions written per year in the United States, according to background information in the article. Untreated AOM has a high rate of natural resolution, with similar rates of complications whether antibiotics are prescribed or withheld. Resistance to antibiotics is a major public health concern worldwide and is associated with the widespread use of antibiotics.
David M. Spiro, M.D., M.P.H., formerly of the Yale University School of Medicine, New Haven, Conn., and colleagues conducted a study to determine whether treatment of AOM using a "wait-and-see prescription" (WASP) significantly reduced use of antibiotics compared with a "standard prescription" (SP), and evaluated the effects of this intervention on clinical symptoms and adverse outcomes. Overall, 283 children with AOM aged 6 months to 12 years seen in an emergency department were randomly assigned to receive either a WASP (n = 138) or a SP (n = 145). All patients received ibuprofen and ear analgesic drops for use at home. Phone interviews were conducted after enrollment to determine outcomes. The trial was conducted between July 2004 and July 2005.
The researchers found that the WASP significantly reduced the use of antibiotics. Substantially more parents in the WASP group did not fill the antibiotic prescription, compared to the SP group (62 percent vs. 13 percent). There was no statistically significant difference between the groups in the frequency of subsequent fever, otalgia (ear ache), or unscheduled visits for medical care. The patients in the WASP group whose parents filled the prescription reported they did so because of fever (60 percent), otalgia (34 percent), or fussy behavior (6 percent). No serious adverse events were reported for patients in the study.
"This randomized controlled trial has provided evidence that the WASP strategy significantly reduces the use of antibiotics in an urban population presenting to an emergency department and may be an alternative to routine treatment of AOM with antibiotics. Wait-and-see prescriptions remain controversial as most pediatricians in the United States have been trained to routinely prescribe antibiotics for AOM and believe that many parents expect a prescription; a small minority of practitioners who care for children routinely use watchful waiting.
"The WASP approach may interrupt the cycle of antibiotic prescription, the expectation of parents to immediately treat AOM with an antibiotic, and subsequent medical visits for this illness. The risks of antibiotics, including gastrointestinal symptoms, allergic reactions, and accelerated resistance to bacterial pathogens must be weighed against their benefits for an illness that, for the most part, is self limited. The routine use of WASP for AOM will reduce both the costs and adverse effects associated with antibiotic treatment and should reduce selective pressure for organisms resistant to commonly used antimicrobials,"the authors conclude.
JAMA. 2006;296:1235-1241
Editor's Note: Dr. Spiro is now with Oregon Health and Science University, Portland. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
|
|
Siemens
SONIC innovations
SeboTek
Starkey
Sycle.net
Unitron
Oticon Medical
Hear USA
Beltone
AuDNet
Cochlear
Bio-Logic
AudioSync
ReSound
Comfort Audio
Otometrics
Interton
Oaktree Products
EarWorksInc.com
Interacoustics
MicroTech
Hansaton
Oticon
Phonak
Rayovac
